Skip to main content

Clinical Trial Results


Dr. David Austin and Dr. C. Michael Gibson Discuss: Preventing Cardiac Damage In Patients Treated For Breast Cancer And Lymphoma: A Phase 3 Randomized, Open Label, Blinded Endpoint, Superiority Trial Of Enalapril To Prevent Anthracycline-induced Cardiotoxicity (PROACT)

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [1.85 MB]

Disclosures: TBD